HilleVax to Participate in Fireside Chat at the 2023 Cantor Global Healthcare Conference
September 26, 2023 16:01 ET
|
HilleVax, Inc.
BOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it...
Global COVID-19 Vaccines Strategic Business Analysis Report 2023-2025: With New Strains Emerging at an Alarming Rate, Focus Shifts to Booster Doses & Vaccine Tweaking
September 25, 2023 08:58 ET
|
Research and Markets
Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The "COVID-19 Vaccines: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global COVID-19 Vaccines Market to...
HilleVax Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
September 25, 2023 07:00 ET
|
HilleVax, Inc.
BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it...
HilleVax Announces Pricing of Public Offering of Common Stock
September 19, 2023 20:05 ET
|
HilleVax, Inc.
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced the...
HilleVax Announces Proposed Public Offering of Common Stock
September 19, 2023 16:09 ET
|
HilleVax, Inc.
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it...
Global Influenza Vaccines Research Analysis Report 2023-2030: Persons Vaccinated, Key Company Analysis, Emerging Players Profile, Vaccines in Clinical Development, Major Deals and Recent Developments
August 31, 2023 10:36 ET
|
Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Influenza Vaccines Market, Persons Vaccinated, Key Company Analysis, Emerging Players Profile, Promising Influenza Vaccines in Clinical...
Global Influenza Vaccines Research Analysis Report 2023-2030: Persons Vaccinated, Key Company Analysis, Emerging Players Profile, Vaccines in Clinical Development, Major Deals and Recent Developments
August 31, 2023 10:34 ET
|
Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Influenza Vaccines Market, Persons Vaccinated, Key Company Analysis, Emerging Players Profile, Promising Influenza Vaccines in Clinical...
HilleVax Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
August 14, 2023 07:00 ET
|
HilleVax, Inc.
BOSTON, Aug. 14, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial...
Preventive Vaccines Market to Reach $94.70 Billion by 2028: Growing Demand for Immunization Programs and Technological Advancements Drive Growth
July 31, 2023 06:23 ET
|
Research and Markets
Dublin, July 31, 2023 (GLOBE NEWSWIRE) -- The "Preventive Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2023-2028)" report has been added to ResearchAndMarkets.com's...
Europe Vaccine Packaging Market Insights Report 2023: A $1.48 Billion Market by 2028 - EU5 Dominated the Market in 2022 with a Share of 53.76%
June 26, 2023 05:23 ET
|
Research and Markets
Dublin, June 26, 2023 (GLOBE NEWSWIRE) -- The "Europe Vaccine Packaging Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering. The Europe vaccine...